Doctors nationwide have been urged to halt the use of Themis-manufactured bupivacaine for spinal anaesthesia. This urgent advisory from the Indian Society of Anaesthesiologists follows reports of serious adverse events linked to the drug. Hospitals are instructed to segregate and withdraw existing stocks, switching to alternative brands to ensure patient safety while investigations are ongoing.